Journal article
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
Abstract
BACKGROUND: Excessive anticoagulation due to warfarin use is associated with hemorrhage. Subcutaneously administered vitamin K has not been evaluated for the treatment of warfarin-associated coagulopathy, yet it is widely used.
OBJECTIVE: To show that oral vitamin K is more effective than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy.
Authors
Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
Journal
Annals of Internal Medicine, Vol. 137, No. 4, pp. 251–254
Publisher
American College of Physicians
Publication Date
August 20, 2002
DOI
10.7326/0003-4819-137-4-200208200-00009
ISSN
1056-8751